Bal Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
97.08
81.76
92.68
70.54
82.64
Other Income Qtr Cr2.450.100.140.160.19
Operating Revenues Qtr94.6381.6692.5470.3982.45

*All values are in Cr.

Operating Expenses Qtr
85.03
73.87
84.85
63.94
74.29
Operating Profit Qtr
9.59
7.79
7.70
6.44
8.16
EBIDT Qtr Cr
12.05
7.89
7.84
6.60
8.35
Depreciation Qtr
2.16
2.96
2.42
2.53
2.09
Net Profit Qtr
5.47
0.89
0.95
0.08
1.60
Basic EPS Qtr
3.73
0.54
0.62
0.06
1.03
Open Demat Account
or Resume your Application
+91 -

personImage